Imagin Medical Inc
CNSX:IME
Net Margin
Imagin Medical Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
I
|
Imagin Medical Inc
CNSX:IME
|
162.5k CAD | N/A | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
219.6B USD |
32%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
206.8B USD |
29%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
149.6B USD |
14%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
135.9B USD |
12%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
121B USD |
14%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
57.2B USD |
25%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
49.1B EUR |
9%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
52.1B USD |
8%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.8B USD |
23%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
36.5B USD |
27%
|
Imagin Medical Inc
Glance View
Imagin Medical, Inc. engages in the development and provision of medical imaging products. The company is headquartered in Vancouver, British Columbia. The firm is engaged in the research, development and commercialization of medical devices in the bio-chemistry industry The Company’s product, the i/Blue Imaging System, with its optics and light sensors that is focused on detecting cancer for removal and helping to reduce recurrence rates.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Imagin Medical Inc's most recent financial statements, the company has Net Margin of 0%.